ARTICLE | Company News
OncoPep, Dana-Farber Cancer Institute deal
February 20, 2012 8:00 AM UTC
The institute granted OncoPep exclusive, worldwide rights to develop and commercialize multi-peptide cancer vaccine technology, including PVX-410. OncoPep plans to begin a Phase I/IIa trial of the va...